Tenaya Therapeutics (TNYA) Proxy filing summary

Executive summary

• Special meeting set for Dec. 9, 2026; stockholders will vote on authorizing a 1-for-10 to 1-for-25 reverse split, with the board selecting the ratio and deciding whether to proceed. The board recommends FOR.

Voting matters and shareholder proposals

• Record date: Oct. 19, 2026; each common share carries one vote. Approval requires votes FOR to exceed votes AGAINST; abstentions have no effect.

• Meeting is virtual at 8:00 a.m. Pacific Time; eligible holders can vote online, by phone, mail, or during the webcast.

Board of directors and corporate governance

• Board unanimously approved and recommended the amendment on Sept. 17, 2026; if approved, it may set a ratio within the authorized range or abandon the split before the one-year anniversary of the meeting.

• Board may elect not to implement the split before the amendment takes effect if it determines the action is no longer in stockholders’ best interests.